Online Adaptive Radiotherapy Systems Market Report 2026

The online adaptive radiotherapy systems market size has grown rapidly in recent years. It will grow from $1.06 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing cancer incidence, rising demand for precision radiation therapy, growing use of real-time imaging, increasing oncology infrastructure investment, rising need to minimize side effects, growing clinical acceptance of adaptive therapy, increasing integrated radiotherapy solutions, rising awareness among clinicians, growing need for improved targeting accuracy, increasing radiotherapy technology R&D.

The online adaptive radiotherapy systems market size is expected to see rapid growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to rising cancer cases in developing regions, growing investment in oncology advancement, increasing demand for personalized treatment, growing use of imaging-guided radiotherapy, rising adoption of dose-adaptation workflows, increasing global healthcare spending, growing institutional support for advanced radiotherapy, rising collaborations between tech firms and hospitals, increasing use of remote radiotherapy systems, growing awareness of adaptive therapy. Major trends in the forecast period include advancement in ai-driven solutions, advancement in automation technologies, advancement in data analytics applications, innovation in product design and functionality, innovation in process optimization, innovation in sustainable and eco-friendly methods, integration of iot and smart devices, integration of cloud-based platforms, integration of predictive analytics for decision making, integration of personalized and customized solutions.

The increasing prevalence of cancer is expected to drive the growth of the online adaptive radiotherapy systems market in the coming years. Cancer is a disease marked by the uncontrolled growth and spread of abnormal cells, which can damage surrounding tissues and organs if not treated effectively. Its rising prevalence is linked to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, increasing the likelihood of developing various cancers. Online adaptive radiotherapy systems aid in cancer management by continuously adjusting radiation treatment plans in real time based on changes in tumor size, shape, or patient anatomy. They enhance patient outcomes by improving treatment precision, minimizing damage to healthy tissues, and increasing overall therapy effectiveness. For example, in October 2025, NHS Digital, a UK government organization, reported 354,820 new cancer diagnoses in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022. Prostate cancer was the most commonly diagnosed cancer, with 58,137 new cases, reflecting a 6% increase from the previous year. Consequently, the rising prevalence of cancer is propelling the growth of the online adaptive radiotherapy systems market.

Leading companies in the online adaptive radiotherapy systems market are focusing on developing advanced technologies, such as the HyperSight imaging solution, to enhance workflow automation, treatment personalization, and clinical outcomes in cancer care. The HyperSight imaging solution is a high-speed cone-beam CT imaging platform integrated into radiotherapy systems, providing CT‑like image quality, accurate Hounsfield Units, and an expanded field of view to support precise, workflow-efficient adaptive radiation treatment. For example, in July 2024, Varian Medical Systems Inc., a US-based provider of radiotherapy solutions, introduced a new functionality for its Ethos adaptive radiotherapy system to expand versatility and connectivity for real-time treatment adaptation. The updates provide clinical teams with streamlined daily adaptation workflows across multiple anatomical sites, improved algorithms for the Intelligent Optimization Engine enabling faster planning and dose delivery, integration of HyperSight imaging data directly into the planning software for precise same-day anatomical dose calculations, and an expanded library of AI-segmented anatomical structures to reduce manual contouring time. These enhancements also enable seamless data exchange with oncology management systems, improving both clinical and operational efficiency in adaptive radiotherapy delivery.

In May 2024, Radformation Inc., a US-based company specializing in radiation oncology workflow automation and software solutions, acquired Limbus AI for an undisclosed sum. Through this acquisition, Radformation enhanced its software offerings for contouring automation and adaptive radiotherapy planning workflows, improving its capacity to optimize online adaptive planning and precise treatment delivery. Limbus AI is a US-based provider of AI-driven contouring and treatment planning software for radiation therapy.

Major companies operating in the online adaptive radiotherapy systems market are Hitachi Ltd., Siemens Healthineers AG, General Electric (GE) Healthcare, Sumitomo Heavy Industries Ltd., Elekta AB, United Imaging Healthcare Co. Ltd., Mirion Technologies Inc., Ion Beam Applications S.A., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, Mevion Medical Systems Inc., ViewRay Inc., Vision RT Ltd., Provision Healthcare LLC, Optivus Proton Therapy Inc., Mvision AI Ltd., Radformation Inc., ProNova Solutions LLC, Therapanacea SAS, Spectronic Medical AB, OncoSoft Inc., Perspective Therapeutics Inc.

North America was the largest region in the online adaptive radiotherapy systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the online adaptive radiotherapy systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the online adaptive radiotherapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the online adaptive radiotherapy systems market by increasing costs of imported imaging hardware, linear accelerator components, advanced sensors, and specialized computing systems required for real-time treatment adaptation. hospitals and cancer centers in north america and europe are most affected due to reliance on imported high-value medical devices, while asia-pacific faces higher capital expenditure for technology upgrades. these tariffs are contributing to longer procurement cycles and higher system installation costs. however, they are also encouraging localized manufacturing, regional assembly of radiotherapy components, and increased collaboration between domestic technology providers and healthcare institutions.

Online adaptive radiotherapy systems are advanced radiation therapy technologies that adjust treatment plans in real time according to the patient’s current anatomy and tumor position. They utilize continuous imaging and AI-driven analysis to modify radiation delivery immediately before or during treatment. This approach increases precision, reduces exposure to healthy tissue, and enhances overall treatment effectiveness.

The primary components of online adaptive radiotherapy systems are hardware, software, and services. Hardware includes advanced radiation delivery and imaging systems that enable real-time treatment plan adaptation based on anatomical and tumor changes during sessions. The product types include MRI-Linac systems, CT-Linac systems, cone beam computed tomography-based systems, and ultrasound-guided systems, supported by technologies such as magnetic-resonance-guided online adaptive radiotherapy, computed tomography or cone beam computed tomography-guided online adaptive radiotherapy, and artificial-intelligence-driven adaptive planning, used in applications including prostate cancer, head and neck cancer, lung cancer, breast cancer, and others, among end users such as hospitals, cancer treatment centers, research institutes, and others.

The online adaptive radiotherapy systems consists of revenues earned by entities by providing services such as real-time treatment plan modification, advanced imaging integration, precision radiation delivery, and continuous monitoring of anatomical changes during therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The online adaptive radiotherapy systems market consists of sales of advanced imaging-guided radiotherapy platforms, adaptive treatment planning software, integrated radiation delivery systems, and related real-time monitoring technologies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.